Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (19020)	2/23/1999 2:32:00 AM
From: 777 Captain	Read Replies (1) \| Respond to of 23519

Hello AT. Agree that it can't go much lower. We're already pretty close to zero. After deducting commissions, it could possibly be a sub-zero trade. Have to believe that a company with the wherewithal of Astra would bother to mention Muse if they didn't intend for it to be a part of their product arsenal. I'm counting on it. At the same time, I fully expect Astra to negotiate the absolutely, positively best deal for their shareholders. I'm thinking it could prove to be a reality check for the likes of LW and the other VVUS board members. I seriously doubt that VVUS if going to survive. My guess is that they become part of a conglomerate. That could be the sticking point in the negotiations. We should know soon enough. Regards.

To: AlienTech who wrote (19020)	2/23/1999 2:32:00 AM
From: VLAD	Respond to of 23519

Alien, I doubt there is anyone here who seriously followed Vivus since 1997 who would have expected a sub $6.00 Vivus. I remember the infamous DR BOND whose posts initially sparked an interest for me in this stock. I remember last spring when Vivus broke below 8 and I had a conversation with him. He didn't see much more downside potential from the high 7's and then the CRUT upgrade gave us a quick double back over 14. These small cap NASDAQ stock are tough to figure out. They do not follow a whole lot of logic. How can we justify a $2 Vivus at this point in time as compared to a $40 Vivus in early 1997 before a single quarter of product sales were reported? I'm sure we can go over a whole bunch of companies that have much worse fundamentals and trade above 10. I just hate watching a small company that produces a product that helps humanity get crushed thanks to all the manipulation that has occurred. Certainly Wilson's mistakes haven't helped but I still don't think they justify a $2.00 stock. Maybe a $6 to $7 stock but not a $2 to $3 stock.